BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Tragara Pharmaceuticals, Inc. 

10955 Vista Sorrento Parkway
Suite 120
San Diego  California  92130  U.S.A.
Phone: 858-350-6911 Fax: 858-350-6925


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Tragara Pharmaceuticals, Inc. Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients 6/7/2011 8:14:40 AM    More...
Tragara Pharmaceuticals, Inc.' Apricoxib Reverses EMT, a Key Process for Cancer Progression and Metastasis 5/26/2011 5:00:38 PM    More...
Tragara Pharmaceuticals, Inc. Initiates Phase I Clinical Program for TG02 9/9/2010 10:32:45 AM    More...
Patient Enrollment Complete in Tragara Pharmaceuticals, Inc.'s Phase II Trial of Capoxigem(R) in Non-Small Cell Lung Cancer 4/6/2010 11:20:14 AM    More...
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million Each to Intellikine, Inc. and Tragara Pharmaceuticals, Inc. to Advance Next-Generation Therapies for Multiple Myeloma 3/29/2010 1:07:43 PM    More...
Tragara Pharmaceuticals, Inc. Raises $5 Million 2/9/2010 7:55:48 AM    More...
S*Bio and Tragara Pharmaceuticals, Inc. Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317; S*BIO Eligible to Receive Up to $112.5 Million 1/21/2009 6:39:47 AM    More...
Tragara Pharmaceuticals, Inc. Announces Corporate Launch and Series A Financing 3/14/2007 10:29:25 AM    More...

//-->